Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels

Given the increased prevalence of cardiovascular disease in the world, the search for genetic variations that impact risk factors associated with the development of this disease continues. Multiple genetic association studies demonstrate that procollagen C-proteinase enhancer 2 (PCPE2) modulates HDL...

Full description

Bibliographic Details
Main Authors: Omar L. Francone, Brian Y. Ishida, Margarita de la Llera-Moya, Lori Royer, Christiane Happe, Jian Zhu, Robert J. Chalkey, Peter Schaefer, Cheryl Cox, Al Burlingame, John P. Kane, George H. Rothblat
Format: Article
Language:English
Published: Elsevier 2011-11-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520350872
id doaj-41e1133ed2ab4ba59e70694a3664f103
record_format Article
spelling doaj-41e1133ed2ab4ba59e70694a3664f1032021-04-28T05:59:15ZengElsevierJournal of Lipid Research0022-22752011-11-01521119741983Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levelsOmar L. Francone0Brian Y. Ishida1Margarita de la Llera-Moya2Lori Royer3Christiane Happe4Jian Zhu5Robert J. Chalkey6Peter Schaefer7Cheryl Cox8Al Burlingame9John P. Kane10George H. Rothblat11Department of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Inc., Groton, CT; To whom correspondence should be addressed.Cardiovascular Research Institute University of California, San Francisco, San Francisco, CADivision of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PADepartment of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Inc., Groton, CTMax Planck Institute of Immunobiology and Epigenetics, D-Freiburg, GermanyDepartment of Cardiovascular and Metabolic Diseases, Global Research and Development, Pfizer, Inc., Groton, CTDepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CACardiovascular Research Institute University of California, San Francisco, San Francisco, CACardiovascular Research Institute University of California, San Francisco, San Francisco, CADepartment of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CACardiovascular Research Institute University of California, San Francisco, San Francisco, CADivision of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, PAGiven the increased prevalence of cardiovascular disease in the world, the search for genetic variations that impact risk factors associated with the development of this disease continues. Multiple genetic association studies demonstrate that procollagen C-proteinase enhancer 2 (PCPE2) modulates HDL levels. Recent studies revealed an unexpected role for this protein in the proteolytic processing of pro-apolipoprotein (apo) A-I by enhancing the cleavage of the hexapeptide extension present at the N-terminus of apoA-I. To investigate the role of the PCPE2 protein in an in vivo model, PCPE2-deficient (PCPE2 KO) mice were examined, and a detailed characterization of plasma lipid profiles, apoA-I, HDL speciation, and function was done. Results of isoelectric focusing (IEF) electrophoresis together with the identification of the amino terminal peptides DEPQSQWDK and WHVWQQDEPQSQWDVK, representing mature apoA-I and pro-apoA-I, respectively, in serum from PCPE2 KO mice confirmed that PCPE2 has a role in apoA-I maturation. Lipid profiles showed a marked increase in plasma apoA-I and HDL-cholesterol (HDL-C) levels in PCPE2 KO mice compared with wild-type littermates, regardless of gender or diet. Changes in HDL particle size and electrophoretic mobility observed in PCPE2 KO mice suggest that the presence of pro-apoA-I impairs the maturation of HDL. ABCA1-dependent cholesterol efflux is defective in PCPE2 KO mice, suggesting that the functionality of HDL is altered.http://www.sciencedirect.com/science/article/pii/S0022227520350872apolipoprotein A-I synthesisPCPE2high density lipoprotein metabolismcholesterol efflux
collection DOAJ
language English
format Article
sources DOAJ
author Omar L. Francone
Brian Y. Ishida
Margarita de la Llera-Moya
Lori Royer
Christiane Happe
Jian Zhu
Robert J. Chalkey
Peter Schaefer
Cheryl Cox
Al Burlingame
John P. Kane
George H. Rothblat
spellingShingle Omar L. Francone
Brian Y. Ishida
Margarita de la Llera-Moya
Lori Royer
Christiane Happe
Jian Zhu
Robert J. Chalkey
Peter Schaefer
Cheryl Cox
Al Burlingame
John P. Kane
George H. Rothblat
Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels
Journal of Lipid Research
apolipoprotein A-I synthesis
PCPE2
high density lipoprotein metabolism
cholesterol efflux
author_facet Omar L. Francone
Brian Y. Ishida
Margarita de la Llera-Moya
Lori Royer
Christiane Happe
Jian Zhu
Robert J. Chalkey
Peter Schaefer
Cheryl Cox
Al Burlingame
John P. Kane
George H. Rothblat
author_sort Omar L. Francone
title Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels
title_short Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels
title_full Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels
title_fullStr Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels
title_full_unstemmed Disruption of the murine procollagen C-proteinase enhancer 2 gene causes accumulation of pro-apoA-I and increased HDL levels
title_sort disruption of the murine procollagen c-proteinase enhancer 2 gene causes accumulation of pro-apoa-i and increased hdl levels
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2011-11-01
description Given the increased prevalence of cardiovascular disease in the world, the search for genetic variations that impact risk factors associated with the development of this disease continues. Multiple genetic association studies demonstrate that procollagen C-proteinase enhancer 2 (PCPE2) modulates HDL levels. Recent studies revealed an unexpected role for this protein in the proteolytic processing of pro-apolipoprotein (apo) A-I by enhancing the cleavage of the hexapeptide extension present at the N-terminus of apoA-I. To investigate the role of the PCPE2 protein in an in vivo model, PCPE2-deficient (PCPE2 KO) mice were examined, and a detailed characterization of plasma lipid profiles, apoA-I, HDL speciation, and function was done. Results of isoelectric focusing (IEF) electrophoresis together with the identification of the amino terminal peptides DEPQSQWDK and WHVWQQDEPQSQWDVK, representing mature apoA-I and pro-apoA-I, respectively, in serum from PCPE2 KO mice confirmed that PCPE2 has a role in apoA-I maturation. Lipid profiles showed a marked increase in plasma apoA-I and HDL-cholesterol (HDL-C) levels in PCPE2 KO mice compared with wild-type littermates, regardless of gender or diet. Changes in HDL particle size and electrophoretic mobility observed in PCPE2 KO mice suggest that the presence of pro-apoA-I impairs the maturation of HDL. ABCA1-dependent cholesterol efflux is defective in PCPE2 KO mice, suggesting that the functionality of HDL is altered.
topic apolipoprotein A-I synthesis
PCPE2
high density lipoprotein metabolism
cholesterol efflux
url http://www.sciencedirect.com/science/article/pii/S0022227520350872
work_keys_str_mv AT omarlfrancone disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT brianyishida disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT margaritadelalleramoya disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT loriroyer disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT christianehappe disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT jianzhu disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT robertjchalkey disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT peterschaefer disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT cherylcox disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT alburlingame disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT johnpkane disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
AT georgehrothblat disruptionofthemurineprocollagencproteinaseenhancer2genecausesaccumulationofproapoaiandincreasedhdllevels
_version_ 1721504689915166720